NCT00215579View on ClinicalTrials.gov

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

PHASE4CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

SchizophreniaSchizoaffective Disorder

Interventions

DRUG

Depot Risperidone Microsphere (Consta)

Trial Locations (1)

27509

John Umstead Hospital, Butner

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

Janssen, LP

INDUSTRY

lead

Duke University

OTHER